Home Search
cancer - search results
If you're not happy with the results, please do another search
Immunoscore®: From the science to the clinical evidence in colon cancer
Jérôme Galon, Director of Research and Head of the Laboratory of Integrative Cancer Immunology at INSERM, explains Immunoscore®, an in vitro diagnostic test that predicts the risk of relapse in colon cancer patients.
Point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond
DiaChemo is a European project developing a platform technology for point-of-care devices for therapeutic drug monitoring in cancer treatment and beyond, reveals Dr Silke Krol, Head of the Translational Nanotechnology Lab and Coordinator of the DIACHEMO Project.
The role of heat shock proteins (HSPs) in cancer cells
Chester Medical School highlights the importance of heat shock proteins (HSPs) in cancer cells and how we might utilise them therapeutically
Northern Ireland announce roll out of new bowel cancer screening test
The Department of Health in Northern Ireland pledge to replace the bowel cancer screening test in the country with the new, more accurate Faecal Immunochemical Test (FIT) from early 2020.
Nano DDS technology contributes to next-generation cancer immunotherapy
Dr Takashi Nakamura from Hokkaido University challenges the potential of nano-tech based drug delivery system (Nano DDS) in the development of next-generation cancer immunotherapy.
European Elections 2019: Beating childhood cancer
The European Elections 2019 Manifesto for the Paediatric Oncology & Haematology community has been launched, and it prioritises beating childhood cancer to aim for zero deaths.
Japan: Driving forward cancer research through collaboration
The work of the Japanese Cancer Association in driving forward cancer research through collaboration is charted here, including a push on basic and translational research.
The advancement of cancer research for the public benefit
European Association for Cancer Research’s Chief Executive Officer, Jane Smith, explains why the advancement of cancer research is purely for the public benefit, as well as the importance of collaboration in the field.
New drugs could stop ovarian cancer
Researchers at The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.
Towards Precision Oncology in Breast Cancer
Predicting Response to Neoadjuvant Chemotherapy Using Tumor Vasculature Characteristics.
The challenges of living with a diagnosis of Cancer and Dementia
For this year’s World Cancer Day, we spoke to Admiral Nurse, Debby Veigas, around the challenges that caring for someone with dementia and cancer brings.
Parents call for teachers to teach children about the signs and symptoms of cancer
Two-thirds of parents think teachers should teach school children about the signs and symptoms of cancer, it has emerged
A trans-disciplinary approach to cancer research
The use of a trans-disciplinary approach to cancer research is necessary for complex systems like tumors.
ChiLTERN: European project to improve outcome of children with liver cancer
In this analysis, Professor Keith Wheatley tells us about The ChiLTERN project, the most comprehensive research study ever undertaken in children’s liver cancer
Point-of-care devices technology for therapeutic drug monitoring in cancer treatment and beyond
Christian Siebel and Dott.ssa Bianca Posocco detail the work of DIACHEMO, a Euroepan project developing a platform technology for point-of-care devices for chemotherapeutics and other drugs.
Bowel cancer – time to test at an earlier age
Your toilet habits can help determine what is going on inside your body and with Brits spending the equivalent of eight months of their adult life sat on the toilet, it is time to test for bowel cancer at an earlier age
Prostate cancer: A riddle wrapped in a mystery inside an enigma
Professor Malcolm Mason, Cancer Research UK’s Prostate Cancer Expert reveals why prostate cancer is a riddle wrapped in a mystery inside an enigma
Bowel cancer screening should start at age 50, according to expert committee
The independent expert screening committee has recommended that bowel cancer screening in England should in future start at age 50 to prevent late diagnosis
Call for free dental care for mouth cancer patients to put an end to...
The Oral Health Foundation is calling for free dental care for mouth cancer patients to combat the discriminatory costs of ongoing healthcare that survivors are often burdened with
Mouth Cancer Action Month: What causes mouth cancer?
Dr. Harold Katz, dentist, bacteriologist and developer of The Breath Company discusses what are the main causes of mouth cancer in aid of Mouth Cancer Action Month
